AMEH:NSD-Apollo Medical Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 54.16

Change

-1.11 (-2.01)%

Market Cap

USD 3.35B

Volume

0.32M

Avg Analyst Target

USD 92.00 (+69.87%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

Apollo Medical Holdings Inc (AMEH) Stock Analysis:
Based on the Apollo Medical Holdings Inc stock forecasts from 1 analysts, the average analyst target price for Apollo Medical Holdings Inc is USD 92.00 over the next 12 months. Apollo Medical Holdings Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Apollo Medical Holdings Inc is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Apollo Medical Holdings Inc’s stock price was USD 54.16. Apollo Medical Holdings Inc’s stock price has changed by -10.12% over the past week, -14.77% over the past month and +141.57% over the last year.

About

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based health ...Read More

Company Website : https://www.apollomed.net

Address : 1668 South Garfield Avenue, Alhambra, CA, United States, 91801

Employees : 630

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.17

52 Week High : 133.23

Short Ratio : 10.34

52 Week Low : 20.51

Shorted Shares : 5,139,149

200 Day Moving Average : 68.15

Shorted Shares Previous Month : 4,991,125

50 Day Moving Average : 81.82

Shares Held By Insiders : 32.52%

Short Percentage : 13.59%

Shares Held by Institutions : 31.35%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

-0.71 (-1.30%)

 USD5.18B 47.80 14.39
AMED Amedisys Inc

-2.86 (-2.10%)

 USD4.79B 22.05 15.09
ENSG The Ensign Group Inc

-1.39 (-1.80%)

 USD4.44B 23.73 17.32
SGRY Surgery Partners Inc

-1.42 (-3.15%)

 USD4.26B 63.00 19.17
LHCG LHC Group Inc

-2.85 (-2.28%)

 USD4.16B 31.67 17.64
PRSC The Providence Service Corpora..

N/A

 USD2.21B 74.23 15.08
HCSG Healthcare Services Group Inc

+0.36 (+2.03%)

 USD1.40B 19.73 9.38
ADUS Addus HomeCare Corporation

-1.25 (-1.55%)

 USD1.35B 33.62 21.81
TVTY Tivity Health Inc

-0.54 (-2.18%)

 USD1.25B 10.59 6.97
AVAH Aveanna Healthcare Holdings In..

-0.11 (-1.87%)

 USD1.17B N/A 10.25

ETFs Containing AMEH

Symbol Name Weight Mer Price(Change) Market Cap
IWC iShares Micro-Cap ETF 0.00 % 0.60 %

-2.25 (-1.72%)

 USD1.25B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

-1.19 (-0.92%)

 USD0.42B
XSMO Invesco S&P SmallCap Mome.. 0.00 % 0.39 %

-1.13 (-2.12%)

 USD0.19B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -26.29% 12% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.29% 12% F 8% F
Trailing 12 Months  
Capital Gain 141.57% 90% A- 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 141.57% 90% A- 98% A+
Trailing 5 Years  
Capital Gain 428.91% 87% B+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 428.91% 87% B+ 93% A
Average Annual (5 Year Horizon)  
Capital Gain 82.48% 90% A- 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.48% 90% A- 92% A-
Risk Return Profile  
Volatility (Standard Deviation) 129.66% 25% F 11% F
Risk Adjusted Return 63.62% 70% C- 81% B-
Market Capitalization 3.35B 79% C+ 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.41 41% F 25% F
Price/Book Ratio 9.56 25% F 13% F
Price / Cash Flow Ratio 72.62 8% F 6% F
EV/EBITDA 27.19 21% F 27% F
Management Effectiveness  
Return on Equity 16.98% 77% C+ 83% B
Return on Invested Capital 4.85% 44% F 64% D
Return on Assets 9.03% 86% B 91% A-
Debt to Equity Ratio 69.59% 30% F 29% F
Technical Ratios  
Short Ratio 10.34 8% F 5% F
Short Percent 13.59% 4% F 12% F
Beta 0.17 85% B 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.